Justia Products Liability Opinion Summaries

In the multidistrict National Prescription Opiate Litigation, municipalities from across the nation, Indian Tribes, and other entities allege that opioid manufacturers, distributors, pharmacies, and retailers acted in concert to mislead medical professionals into prescribing, and millions of Americans into taking and often becoming addicted to, opiates. Two northeast Ohio counties, Trumbull and Lake, alleged that national pharmaceutical chains “created, perpetuated, and maintained” the opioid epidemic by filling prescriptions for opioids without controls in place to stop the distribution of those that were illicitly prescribed and that conduct caused an absolute public nuisance remediable by abatement under Ohio common law.The district court ordered a bellwether trial, after which a jury concluded that the “oversupply of legal prescription opioids, and diversion of those opioids into the illicit market” was a public nuisance in those counties and that defendants “engaged in intentional and/or illegal conduct which was a substantial factor in producing" that nuisance. The district court entered a $650 million abatement order and an injunction requiring defendants to “ensure they are complying fully with the Controlled Substances Act and avoiding further improper dispensing conduct.” On appeal, the Sixth Circuit certified a question of law to the Ohio Supreme Court: Whether the Ohio Product Liability Act, Ohio Revised Code 2307.71, abrogates a common law claim of absolute public nuisance resulting from the sale of a product in commerce in which the plaintiffs seek equitable abatement, including both monetary and injunctive remedies? View "Trumbull County v. Purdue Pharma, L.P." on Justia Law

The Third Circuit Court of Appeals certified a question of law to the Delaware Supreme Court. The question arose in connection with a toxic tort class action in the federal district court for the District of Delaware that was appealed to the Third Circuit. Delaware resident Catherine Baker filed suit individually and on behalf of fellow residents who lived near Atlas Point, a chemical plant that regularly used and emitted ethylene oxide, a dangerous chemical. The question asked whether an increased risk of illness, without present manifestation of a physical harm, was a cognizable injury under Delaware law. Put another way: did an increased risk of harm only constitute a cognizable injury once it manifested in a physical disease? To this, the Supreme Court answered: an increased risk of illness without present manifestation of a physical harm is not a cognizable injury under Delaware law. View "Baker v. Croda Inc." on Justia Law

Hakim, a DuPage County Sheriff’s Office (DCSO) SWAT officer, was accidentally shot by a colleague during a training exercise, using a Safariland “breaching” shotgun round. Breaching rounds assist in breaking down doors by disabling hinges and other attachments on doorframes. When used as intended, they disintegrate harmlessly on impact with a metal attachment mechanism. Hakim’s fellow officer missed the door hinge he was shooting at. The round struck wood, remained live, and hit Hakim in the spine. Hakim’s 13-month recovery required multiple surgeries. He still experiences severe pain. Hakim sued Safariland under Illinois’s strict product liability law. Hakim claimed that the Safariland round was defective in its manufacture and design and that Safariland failed to provide adequate warning that its rounds do not disintegrate if they strike wood instead of metal.A jury found for Safariland on the manufacturing- and design-defect claims, but awarded Hakim $7.5 million on his failure-to-warn claim. The Seventh Circuit affirmed. The fact that the rounds might be complex in some respects does not mean that expert testimony is required for every product liability claim involving them. The jury reasonably could have found Safariland’s warnings inadequate. Even assuming that DCSO was negligent, Safariland’s own failure to warn could constitute an additional proximate cause of Hakim’s injuries. The jury’s award of $7.5 million, “while perhaps on the high side,” was not unreasonable. View "Hakim v. Safariland, LLC" on Justia Law

The Supreme Court made permanent a preliminary writ it issued granting Monsanto Company's petition for a writ of prohibition or mandamus requiring the St. Louis circuit court to transfer venue of five of the six plaintiffs' claims, holding that Missouri law compelled this result.Plaintiffs brought this action claiming that they were injured as a result of exposure to a herbicide manufactured by Monsanto Company and seeking monetary damages. Monsanto filed a motion to transfer venue as to five of the six plaintiffs in this case to St. Louis County but failed to file a motion to transfer in the six plaintiff's case The circuit court subsequently consolidated Plaintiffs' individual claims. Monsanto filed a motion to reconsider, arguing that venue was inappropriate in St. Louis Valley. The circuit court overruled the motion, after which Monsanto sought relief by way of mandamus or prohibition. The Supreme Court granted relief, holding that Mo. Rev. Stat. 508.010.5(1) mandated that venue shall be where Monsanto's registered agent was located as of filing - St. Louis County. View "State ex rel. Monsanto Co. v. Honorable Mullen" on Justia Law

Hoping to minimize her risk of suffering serious complications from future blood clots, Johnson underwent surgery to implant a retrievable intravascular filter–a medical device that is placed in the inferior vena cava to prevent blood clots that develop in the lower body from flowing into the heart and lungs. Johnson’s doctor selected the Meridian filter, which was supposed to be temporary and easily removable. Johnson’s filter migrated and fractured, leaving shards embedded in the wall of her heart and elsewhere. Her surgeon was unable to remove the device safely and fully. As a result, Johnson faces an ongoing risk of infection, pain, and other complications.Johnson sued the manufacturers of the Meridian filter (Bard), claiming that they defectively designed the Meridian filter and failed to warn medical providers about the device’s risks, in violation of Wisconsin law. A jury rejected most of Johnson’s theories but returned a $3.3 million verdict in her favor on her strict liability failure-to-warn count. The Seventh Circuit affirmed, stating that its decision “should not be misinterpreted as our endorsement of some of Johnson’s counsel’s trial tactics.” There was no reversible error in instructing the jury or in permitting certain testimony, in alleged violation of expert witness disclosure requirements. View "Johnson v. C. R. Bard, Inc." on Justia Law

Plaintiff sustained a spinal injury during a rollover car accident in Mexico. Plaintiff, along with his wife (collectively, “Plaintiffs”) filed a claim for damages against General Motors, LLC (“GM”) on theories of strict liability, negligence, and loss of consortium. The district court applied the law of Coahuila, Mexico, under Missouri’s choice of law principles and granted GM’s motion for summary judgment. Plaintiffs appealed the district court’s choice of law decision.   The Eighth Circuit affirmed. The court explained that its conclusion in Azarax that the district court did not abuse its discretion by refusing to allow a party to rely on foreign law does not lead to the conclusion the district court abused its discretion here when it decided the opposite under different facts. Further, the court wrote that after considering the Section 6 factors and the parties’ arguments, it concluded Missouri’s relationship to this case does not overcome the presumption that the place of the injury—Coahuila, Mexico—is the place with the most significant relationship to the parties and occurrence. View "Nicolas Valadez Rey v. General Motors, LLC" on Justia Law

Coloplast Corporation and Coloplast Manufacturing US, LLC (collectively, Coloplast) manufacture and market Restorelle L, a surgical mesh device. Plaintiff sued Coloplast for injuries allegedly caused by the implantation of Restorelle L mesh. After excluding portions of Plaintiff’s expert opinions and testimony, the district court granted summary judgment in favor of Coloplast. On appeal, Plaintiff argued that the district court erred in excluding her expert’s opinion on specific causation and in granting summary judgment on her negligent design claim.   The Eighth Circuit affirmed. The court concluded that the expert’s supplemental declaration was untimely because it was submitted after the deadlines for disclosure of expert reports and completion of all discovery. The court reasoned that Rule 26(e)(2) requires that an expert’s supplement “be disclosed by the time the party’s pretrial disclosures under Rule 26(a)(3) are due.” Rule 26(a)(3)(B), in turn, states that “Unless the court orders otherwise, these disclosures must be made at least 30 days before trial.” Plaintiff maintains that she, therefore, had until thirty days before trial to disclose the expert’s supplemental declaration. However, the court explained that she ignored the caveat that Rule 26’s default timing provision applies only if the court does not order otherwise. Here, the court set deadlines in its scheduling order, those deadlines superseded the default rules, and Plaintiff failed to meet those deadlines. Further, the court wrote that the district court also did not abuse its discretion when it decided to exclude the expert’s report and declaration without considering lesser sanctions. View "Angela Cantrell v. Coloplast Corp." on Justia Law

The First Circuit affirmed the judgment of the district court against Plaintiffs on their action brought against BMW of North America, LLC claiming that a fire that occurred in their garage was the result of a manufacturing or design defect in their 2016 BMW X5 hybrid vehicle, holding that the district court properly concluded that Plaintiffs could not satisfy their burden of proof at trial.Plaintiffs had parked their hybrid BMW vehicle in their garage and were charging it using an extension cord when a fire occurred. Plaintiffs brought this lawsuit claiming that the fire was the result of a manufacturing or design defect in their BMW. Plaintiffs, however, failed to present an expert to support their theory. The district court granted judgment for Defendants. The First Circuit affirmed, holding that, absent expert support for the theory that Plaintiffs presented below, there was no basis for inferring that the accident was caused by a defective product. View "Molinary-Fernandez v. BMW of North America, LLC" on Justia Law

In this products liability matter involving “pelvic mesh” medical devices, the New Jersey Supreme Court considered whether defendant C.R. Bard, Inc., was denied a fair trial by the trial court’s determination that defendant could not present 510(k) clearance evidence -- evidence that, pursuant to 21 U.S.C. § 360c, the devices were allowed to be marketed without premarket clinical trials -- to counter the product liability claims brought by plaintiffs Mary and Thomas Walsh McGinnis. North Carolina surgeon Dr. Elizabeth Barbee implanted Bard’s “Align TO” and “Avaulta Solo” pelvic mesh devices. In the months following surgery, McGinnis had to undergo numerous invasive surgeries to remove the mesh and repair internal damage, with limited success. In 2011, plaintiffs filed suit against defendant Bard under North Carolina law. Counsel agreed that the substantive issues would be tried under the law of North Carolina but that the issue of damages would be tried under New Jersey law. Plaintiffs moved in limine to bar defendant from presenting any evidence of the devices’ 510(k) clearance to the jury. The trial court found the 510(k) evidence inadmissible. The Appellate Division reversed, holding that the exclusion of any 510(k) evidence deprived defendant of a fair trial on the issue of negligence. The Supreme Court agreed that 510(k) evidence was generally inadmissible because the 510(k) clearance process solely determines substantial equivalency, and not safety and efficacy. However, in a products liability claim premised on the reasonableness of a manufacturer’s conduct in not performing clinical trials or studies, the Court held evidence of 510(k) clearance had significant probative value under N.J.R.E. 401 that was not substantially outweighed by the risk of prejudice and potential juror confusion under N.J.R.E. 403. Therefore, under the specific facts and circumstances of this case, the Supreme Court affirmed the Appellate Division and remanded for a new trial. The Court disagreed with the Appellate Division’s decision regarding the scope and admissibility of 510(k) evidence and a Rule 104 hearing. To this, the Supreme Court believed the scope and admissibility of 510(k) evidence should be resolved at the hearing on a motion in limine, which was how the issue was and, presumably, would be raised. View "Hrymoc v. Ethicon, Inc." on Justia Law

Five people were killed when a commercial truck rear-ended a line of traffic on an interstate highway. The truck driver was prosecuted and sentenced to prison for his misconduct. The issue on this appeal was the liability, if any, of the manufacturer of the truck. Plaintiffs, suing on behalf of the heirs and estates of the decedents, contended the manufacturer, Daimler Trucks North America, should have been held liable in tort under design-defect and warning-defect theories of products liability because it failed to equip the truck with two collision-mitigation systems—forward-collision warning and automatic emergency braking—and did not warn of the dangers caused by that failure. The district court granted summary judgment to Daimler. After its review of the district court record, the Tenth Circuit Court of Appeals affirmed, finding many of the arguments made by Plaintiffs on appeal were inadequately preserved for appellate review, and the remaining arguments lacked merit. View "Butler, et al. v. Daimler Trucks North America" on Justia Law